New Times,
New Thinking.

  1. World
  2. Americas
  3. North America
22 October 2013updated 27 Sep 2015 5:32am

Can Big Pharma end the death penalty in the US?

Someone on death row might have an excellent innocence claim or an excellent police corruption claim, but what is saving their life is shortages or litigation over execution drugs.

By Clare Algar

A man walks into a pharmacy with an execution warrant and is given the drugs necessary for execution by lethal injection. This sounds like a very bad joke, but is in fact what is going on at the moment in Ohio. And here is why.

Thirty two states retain the death penalty in the US, but a new obstacle is making it increasingly difficult for them to carry it out. Pharmaceutical companies are taking a moral stand. The manufacturers of the drugs required by state departments of corrections for executions are saying they will not allow their products to be employed in this way. Manufacturers in the UK, US, Denmark, Israel, Switzerland, Germany, Austria and India have taken steps to prevent their drugs being used in executions.

Subscribe to The New Statesman today from only £8.99 per month
Content from our partners
More than a landlord: A future of opportunity
Towards an NHS fit for the future
How drones can revolutionise UK public services